Herbal medicine, also known as herbalism or botanical medicine, is a medical system based on the use of plants or plant extracts that may be eaten or applied to the skin. Since ancient times, herbal medicine has been used by many different cultures throughout the world to treat illness and to assist bodily functions.

Due to the COVID-19 pandemic, the global Organic Herbal Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Organic Herbal Medicine market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Organic Herbal Medicine landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Medicine Function accounting for % of the Organic Herbal Medicine global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Western Herbalism segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.

The global major manufacturers of Organic Herbal Medicine include Tsumura, Schwabe, Madaus, Weleda, Blackmores, Arkopharma, SIDO MUNCUL, Arizona Natural and Dabur, etc. In terms of revenue, the global 3 largest players have a % market share of Organic Herbal Medicine in 2022.

This report focuses on Organic Herbal Medicine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Organic Herbal Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Organic Herbal Medicine Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

• Medicine Function
• Medicinal part
• Active Ingredient

Segment by Application

• Western Herbalism
• Traditional Chinese Medicine
• Others

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E

By Company

• Tsumura
• Schwabe
• Madaus
• Weleda
• Blackmores
• Arkopharma
• SIDO MUNCUL
• Arizona Natural
• Dabur
• Herbal Africa
• Natures Answer
• Bio-Botanica
• Potters
• Zand
• Nature Herbs
• Imperial Ginseng
• Yunnan Baiyao
• Tongrentang
• TASLY
• Zhongxin
• Kunming Pharma
• Sanjiu
• JZJT
• Guangzhou Pharma
• Taiji
• Haiyao

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414